InsidersTradesSigma
Follow the 신흥 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 신흥 has recorded 5 insider filings. Market capitalisation: €130.1bn. The latest transaction was disclosed on 30 June 2026 (Sale). Among the most active insiders: 이용익. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
신흥 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.